Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

Vera Hirsh; Isamu Okamoto; Jeremy K. Hon; Ray D. Page; James Orsini; Hiroshi Sakai; Hui Zhang; Markus F. Renschler; Mark A. Socinski

doi:10.1097/JTO.0000000000000011

Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

Vera Hirsh
, Isamu Okamoto
, Jeremy K. Hon
, Ray D. Page
, James Orsini
, Hiroshi Sakai
, Hui Zhang
, Markus F. Renschler
, Mark A. Socinski

McGill University
Kindai University
Clearview Cancer Institute, Huntsville, Alabama
The Center for Cancer and Blood Disorders, Fort Worth, Texas
Essex Oncology of New Jersey, Belleville, New Jersey
Saitama Cancer Center, Saitama, Japan
Celgene
University of Pittsburgh

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	9
Issue number	1
DOIs	https://doi.org/10.1097/JTO.0000000000000011
State	Published - Jan 1 2014
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1097/JTO.0000000000000011License: Unspecified

Cite this

Hirsh, V., Okamoto, I., Hon, J. K., Page, R. D., Orsini, J., Sakai, H., Zhang, H., Renschler, M. F., & Socinski, M. A. (2014). Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer. Journal of Thoracic Oncology, 9(1). https://doi.org/10.1097/JTO.0000000000000011

Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer. / Hirsh, Vera; Okamoto, Isamu; Hon, Jeremy K. et al.
In: Journal of Thoracic Oncology, Vol. 9, No. 1, 01.01.2014.

Research output: Contribution to journal › Article › peer-review

Hirsh, V, Okamoto, I, Hon, JK, Page, RD, Orsini, J, Sakai, H, Zhang, H, Renschler, MF & Socinski, MA 2014, 'Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.', Journal of Thoracic Oncology, vol. 9, no. 1. https://doi.org/10.1097/JTO.0000000000000011

@article{7c04271c69d44ef39cfc995b15896ccb,

title = "Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.",

author = "Vera Hirsh and Isamu Okamoto and Hon, \{Jeremy K.\} and Page, \{Ray D.\} and James Orsini and Hiroshi Sakai and Hui Zhang and Renschler, \{Markus F.\} and Socinski, \{Mark A.\}",

year = "2014",

month = jan,

day = "1",

doi = "10.1097/JTO.0000000000000011",

language = "American English",

volume = "9",

journal = "Journal of Thoracic Oncology",

number = "1",

}

TY - JOUR

T1 - Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

AU - Hirsh, Vera

AU - Okamoto, Isamu

AU - Hon, Jeremy K.

AU - Page, Ray D.

AU - Orsini, James

AU - Sakai, Hiroshi

AU - Zhang, Hui

AU - Renschler, Markus F.

AU - Socinski, Mark A.

PY - 2014/1/1

Y1 - 2014/1/1

UR - https://www.jto.org/article/S1556-0864(15)30166-0/pdf

U2 - 10.1097/JTO.0000000000000011

DO - 10.1097/JTO.0000000000000011

M3 - Article

VL - 9

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 1

ER -

Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

Disciplines

Access to Document

Other files and links

Cite this